Try our Advanced Search for more refined results
Life Sciences
- 
									October 27, 2025
									Catching Up With Delaware's Chancery CourtThe Delaware Chancery Court and Delaware Supreme Court saw another busy week of disputes spanning biotech milestones, reincorporation showdowns, shareholder voting schemes and cryptocurrency fiduciary rights. 
- 
									October 27, 2025
									Ex-Magellan CEO Avoids Prison Over Faulty Lead TestsThe former CEO of Magellan Diagnostics was sentenced in Massachusetts federal court Monday to a year of home confinement for failing to alert regulators to a problem in the company's lead-testing devices that resulted in inaccurately low lead levels being detected in blood samples. 
- 
									October 27, 2025
									Covington Helps Novartis Buy Avidity Biosciences For $12BSwiss pharmaceutical giant Novartis AG has said it will buy Avidity Biosciences, a U.S. developer of therapeutics for muscle diseases, for approximately $12 billion in a move to boost its neuroscience portfolio. 
- 
									October 24, 2025
									Pfizer Hit With More Suits Over Depo-ProveraThree women sued Pfizer this week in Florida federal court, alleging its hormonal contraceptive birth control shot Depo-Provera caused their brain tumors in the latest claims that the major drugmaker failed to warn of the link. 
- 
									October 24, 2025
									Ohio, Ky. Reps Again Pursue Bill To Make PTAB OptionalA bipartisan pair of legislators in the U.S. House of Representatives are floating a bill that would give patent owners the ability to extinguish challenges to their intellectual property at the Patent Trial and Appeal Board before they start. 
- 
									October 24, 2025
									GNC Franchisee Cos. Largely Lose Bid To Toss Award OrderAn international court judge has largely denied efforts by GNC franchisee businesses in Singapore and the Philippines to set aside an order enforcing arbitral awards totaling about $45 million that also enforced a contractual obligation to assign their 54 stores in Singapore to the health and wellness company. 
- 
									October 24, 2025
									USPTO Chief To Review PTAB Ruling On Tire Sensor PatentU.S. Patent and Trademark Office Director John Squires has decided to step in and examine a Patent Trial and Appeal Board decision from September to consider a challenge to a Cerebrum Sensor Technologies Inc. tire sensor patent. 
- 
									October 24, 2025
									Tricida Investors Win OK Of $14.2M Deal Over Kidney DrugA California federal judge on Thursday granted final approval to a $14.2 million settlement that ends a class action against Tricida Inc. founder Gerrit Klaerner claiming he and the company misled investors on the approval chances for their new kidney disease drug, including nearly $4 million for plaintiffs' counsel. 
- 
									October 24, 2025
									Generic-Drug Makers Want Conn. Price Cap Blocked During SuitA trade group for generic and biosimilar drugmakers is asking a Connecticut federal judge to block the state's new drug price cap during the pendency of its challenge, saying it illegally controls prices on sales made outside the state. 
- 
									October 24, 2025
									Eli Lilly Buying Eye Disease Biotech For Up To $262MRopes & Gray LLP-advised Eli Lilly said Friday it has agreed to acquire Cooley LLP-guided Adverum Biotechnologies, a clinical-stage company developing gene therapies for eye diseases, for up to roughly $262 million. 
- 
									October 24, 2025
									Abbott Wins Third Bellwether In Cow Milk Baby Formula MDLAn Illinois federal judge has given Abbott Laboratories Inc. its third bellwether win in multidistrict litigation alleging that its cow-milk-based baby formula gives infants necrotizing enterocolitis, saying the company successfully demonstrated that the plaintiff's proffered human-milk-based alternative would not be feasible. 
- 
									October 24, 2025
									Taxation With Representation: Latham, Wachtell, Gibson DunnIn this week's Taxation With Representation, Meta announces a joint venture with Blue Owl Capital to fund the development of a data center campus in Louisiana, private equity giants acquire medical technology company Hologic Inc., and National Fuel Gas Co. buys CenterPoint Energy Inc.'s Ohio natural gas utility business. 
- 
									October 23, 2025
									NY AG Sues Vape Shop Owners For Selling To KidsNew York's attorney general is looking to permanently shut down two smoke shops and ban their owners from ever working in the vape industry again, claiming they flagrantly sold illegal flavored vapes to customers including children, according to a petition filed Oct. 23. 
- 
									October 23, 2025
									Ky. Rep. Revives Attempt To Abolish PTAB, Expand EligibilityU.S. Rep. Thomas Massie, R-Ky., said Thursday he's again attempting to overhaul the patent system, including abolishing the Patent Trial and Appeal Board, normalizing injunctions and broadening what can be patented. 
- 
									October 23, 2025
									Chancery Maps Out Math For Hefty Drug Co. Breach InterestA Delaware vice chancellor late Thursday issued a road map for calculating tens of millions of dollars in interest due after a ruling in June that Alexion Pharmaceuticals failed a "best efforts" duty to fulfill an autoimmune drug candidate deal with Syntimmune Inc. 
- 
									October 23, 2025
									Investor Says Biotech Co. Rigged Votes To Expand Share PoolA stockholder of Pennsylvania-based Ocugen Inc. sued the biotech company Thursday in Delaware Chancery Court, alleging that the company's board contrived a "clever" but unlawful scheme to push through a 2024 charter amendment that expanded its authorized share count without the required majority approval. 
- 
									October 23, 2025
									RingConn Settles With Oura After ITC Import BanOuraring Inc. has inked a deal allowing RingConn to keep its smart rings on the U.S. market following the U.S. International Trade Commission's decision to block Ultrahuman and RingConn from importing products it held infringed a wearable computing device patent. 
- 
									October 23, 2025
									Freshly Launched Legal Org. Plans To Protect Abortion DocsA new legal group launched this week aims to support telehealth doctors providing abortion pills and reproductive care, and to further strengthen shield laws protecting those providers from out-of-state prosecutions. 
- 
									October 23, 2025
									Bayer Wants Full Fed. Circ. Scrutiny Of Axed Xarelto ClaimsBayer Pharma Aktiengesellschaft is urging the full Federal Circuit to scrutinize a decision that declined to revive claims in a patent covering its blockbuster blood thinner, saying Wednesday that a panel wrongly concluded the term "clinically proven effective" couldn't count toward the claims' patentability. 
- 
									October 23, 2025
									SEC Being Misled In CBD Fraud Fight, CEO ClaimsThe U.S. Securities and Exchange Commission has "unwittingly" taken the side of a former partner with a terminated licensing agreement, a pharmaceutical CEO told a California federal court this week, asking for summary judgment on the SEC's core claims that he defrauded investors. 
- 
									October 23, 2025
									Ex-Exec Accused Of Stealing IVF Co.'s Trade SecretsThe co-founder of a Garden State genetic testing company abruptly quit, deleted all the data on his company laptop — including the only copy of some materials — then took the trade secrets to help a competitor, according to a lawsuit filed in New Jersey federal court. 
- 
									October 23, 2025
									Eli Lilly Says Pharmacy Mass-Producing Weight Loss DrugDrugmaker Eli Lilly is suing a compounding pharmacy in Texas federal court, alleging the pharmacy ripped off its lucrative weight loss drug, began mass-producing it, and made as much as $2 million per month last year from its misdeeds. 
- 
									October 23, 2025
									Avadel, Jazz Settle Sleep Disorder Drug ClaimsAvadel Pharmaceuticals has announced it reached a global settlement with Irish rival Jazz Pharmaceuticals to dismiss their lawsuits against each other that alleged patent and antitrust violations related to sleep disorder drug Lumryz. 
- 
									October 23, 2025
									Del. Startup Accuses Ex-CEO In Chancery Of Stock SchemeA Delaware pharmaceutical startup has sued its former CEO in the Delaware Chancery Court, accusing him of secretly enriching himself through unauthorized stock issuances and deceptive loans. 
- 
									October 23, 2025
									Feds, Ex-Magellan CEO Still Split Over Sentencing FactorsLawyers for a former Magellan Diagnostics CEO and the government are still at odds over whether a judge should consider the product mislabeling charge she pled guilty to in March to be tantamount to fraud — an assertion the defense says is an attempt by prosecutors to "shoehorn" in allegations never put to proof. 
Expert Analysis
- 
								Series Painting Makes Me A Better Lawyer  Painting trains me to see both the fine detail and the whole composition at once, enabling me to identify friction points while keeping sight of a client's bigger vision, but the most significant lesson I've brought to my legal work has been the value of originality, says Jana Gouchev at Gouchev Law. 
- 
								
								Courts Are Still Grappling With McDonnell, 9 Years Later  The Seventh and D.C. Circuits’ recent decisions in U.S. v. Weiss and U.S. v. Paitsel, respectively, demonstrate that courts are still struggling to apply the U.S. Supreme Court’s 2016 ruling in McDonnell v. U.S., which narrowed the scope of “official acts” in federal bribery cases, say attorneys at Quinn Emanuel. 
- 
								
								AI Will Transform Patent Examination For The Better  The U.S. Patent and Trademark Office's increasing use of artificial intelligence tools will result in patents that are more thoroughly vetted, and patent applicants and practitioners will need to adapt their drafting strategies and address stronger and more sophisticated rejections, say attorneys at Troutman. 
- 
								
								Hybrid Claims In Antitrust Disputes Spark Coverage Battles.png)  Antitrust litigation increasingly includes claims for breach of warranty, product liability or state consumer protection violations, complicating insurers' reliance on exclusions as courts analyze whether these are antitrust claims in disguise, says Jameson Pasek at Caldwell Law. 
- 
								
								Drug Ad Crackdown Demonstrates Admin's Aggressive Stance  Recent actions by the U.S. Food and Drug Administration and U.S. Department of Health and Human Services targeting pharmaceutical companies' allegedly deceptive advertising practices signal an active — potentially even punitive — intent to regulate direct-to-consumer advertising out of existence, say attorneys at King & Spalding. 
- 
								
								Protecting Sensitive Court Filings After Recent Cyber Breach  In the wake of a recent cyberattack on federal courts' Case Management/Electronic Case Files system, civil litigants should consider seeking enhanced protections for sensitive materials filed under seal to mitigate the risk of unauthorized exposure, say attorneys at Redgrave. 
- 
								Series Judging Figure Skating Makes Me A Better Lawyer  Judging figure skating competitions helps me hone the focus, decisiveness and ability to process complex real-time information I need in court, but more importantly, it makes me reengage with a community and my identity outside of law, which, paradoxically, always brings me back to work feeling restored, says Megan Raymond at Groombridge Wu. 
- 
								
								Trending At The PTAB: Petitioners' Settled Expectations  Recent Patent Trial and Appeal Board decisions show that the U.S. Patent and Trademark Office's new "settled expectations" factor is no longer the exclusive domain of patent owners and can also provide petitioners with viable pathways to argue against discretionary denial, say attorneys at Finnegan. 
- 
								
								9th Circ. Ruling May Help Pharma Cos. Avert Investor Claims  The Ninth Circuit's recent decision affirming the dismissal of a securities fraud class action alleging that Talphera deceived investors by marketing a drug with a misleading slogan should give plaintiffs pause before filing similar complaints where snappy slogans are accompanied by copious clarifying information, say attorneys at Simpson Thacher. 
- 
								
								What Ethics Rules Say On Atty Discipline For Online Speech  Though law firms are free to discipline employees for their online commentary about Charlie Kirk or other social media activity, saying crude or insensitive things on the internet generally doesn’t subject attorneys to professional discipline under the Model Rules of Professional Conduct, says Stacie H. Rosenzweig at Halling & Cayo. 
- 
								
								Junior Attys Must Beware Of 5 Common Legal Brief MistakesExcerpt from Practical Guidance.jpg)  Junior law firm associates must be careful to avoid five common pitfalls when drafting legal briefs — from including every possible argument to not developing a theme — to build the reputation of a sought-after litigator, says James Argionis at Cozen O'Connor. 
- 
								Opinion State AGs, Not Local Officials, Should Lead Public Litigation  Local governments’ public nuisance lawsuits can raise constitutional and jurisdictional challenges, reinforcing the principle that state attorneys general — not municipalities — are best positioned to litigate on behalf of citizens when it is warranted, says former Utah Attorney General John Swallow. 
- 
								
								3rd Circ. Clarifies Ch. 11 3rd-Party Liability Scope Post-Purdue  A recent Third Circuit decision that tort claims against the purchaser of a debtor's business belong to the debtor's bankruptcy estate reinvigorates the use of Chapter 11 for the resolution of nondebtor liability in mass tort bankruptcies following last year's U.S. Supreme Court ruling in Purdue Pharma, say attorneys at Sullivan & Cromwell. 
- 
								
								Texas Suit Marks Renewed Focus On Service Kickback Theory.jpg)  After a dormant period at the federal level, a theory of kickback enforcement surrounding nurse educator programs and patient support services resurfaced with a recent state court complaint filed by Texas against Eli Lilly, highlighting for drugmakers the ever-changing nature of enforcement priorities and industry landscapes, say attorneys at Sheppard Mullin. 
- 
								Series Power To The Paralegals: How And Why Training Must Evolve  Empowering paralegals through new models of education that emphasize digital fluency, interdisciplinary collaboration and human-centered lawyering could help solve workforce challenges and the justice gap — if firms, educators and policymakers get on board, say Kristine Custodio Suero and Kelli Radnothy.